Arsenal — 2017 Investments
5 investments dated 2017 · listed companies and verified rows first · show all
Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing.
AgTechBiotechHealthtechChampaign, US
Aaron Gilbertie(CEO)Federico Zuckermann(Executive Officer, Director)
BoardRobert Easter(Director)Paul Olivo(Director)Gary Durack(Director)
Co-investorsMissouri Technology CorporationCultivation CapitalThe Yield LabIllinois VenturesThe Yield Lab Asia Pacific
Boulder, US
Wesley Burgess(Executive Officer)Carl Boni(Executive Officer)Jeff Bowman(Executive Officer, Director)
BoardCraig Burson(Director)James Goldinger(Director)
Board seatChristopher Fountas· per SEC Form D · $5M raise · filed May 2017
Raleigh, US
Thaddeus W. Tarkington(Executive Officer, Director)Kevin J. Barry(Executive Officer, Director)Tom Lotrecchiano(Director)
BoardSteve Dauphin(Director)David E. Gardner(Director)Lister Delgado(Director)
Board seatJohn Trbovich· per SEC Form D · $7M raise · filed Jul 2017
Co-investorsCofounders CapitalElevate Innovation PartnersHatteras Venture Partners
Winter Park, US
Geoff Toffetti(Executive Officer)David Schmeltz(Executive Officer, Director)
BoardZiad Khoury(Director)
Board seatJason Rottenberg· per SEC Form D · $3.3M raise · filed May 2017
San Francisco, US
Abnesh Kumar Raina(Executive Officer, Director)
BoardWilliam T. Heflin(Director)
Board seatJohn Trbovich· per SEC Form D · $5M raise · filed Oct 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.